Healthcare Industry News: Cyberonics
News Release - May 4, 2012
OrthoAccel Technologies, Inc. Announces New Chief Innovation Officer and Vice President of MarketingHOUSTON, May 4, 2012 -- (Healthcare Sales & Marketing Network) -- Kathleen Malaspina has been named Chief Innovation Officer and Vice President of Marketing for OrthoAccel Technologies. In this position, she will oversee marketing, clinical affairs, product innovations and international business development. Of particular focus will be efficient expansion of a global market for OrthoAccel's AcceleDent™ system, an acceleration device to enhance orthodontics.
Ms. Malaspina brings over twenty years of international marketing experience, primarily in the consumer healthcare sector. She held international operational management positions with Motorola, Sanyo and Philips. While at Philips, she was instrumental in the development and growth of the renowned Sonicare brand. More recently, as principal of Malaspina Healthcare Consulting, she worked with Cyberonics, and Sesame Communications. It was as a consultant that Ms. Malaspina first came to work with OrthoAccel Technologies.
"Kathleen is an accomplished executive who brings OrthoAccel significant capacity to quickly establish critical functions in important areas of our business as we scale and grow. The perspective that she brought as a strategic consultant was immediately valuable, and we are excited about her joining the team now in a full-time capacity," commented Mike Lowe, CEO at OrthoAccel.
Ms. Malaspina adds, "This is an extremely exciting time to join the OrthoAccel team and be a part of building the business as we bring this groundbreaking technology to orthodontic care."
Last week, OrthoAccel announced a $10 million equity investment with existing shareholder, S3 Ventures and a new private equity investor, HealthPoint Capital. The primary uses of this investment include executing the AcceleDent market launch plan and working capital. In addition, OrthoAccel plans to expand its sales organization in order to maintain its commitment to customer service as the AcceleDent business continues to grow.
About OrthoAccel® Technologies, Inc.
OrthoAccel's AcceleDent™ product provides faster tooth movement through its FDA approved solution, available now in over fifteen countries around the world. AcceleDent™ works with all existing orthodontic solutions, including standard brackets and aligners, requiring only twenty minutes per day of regular usage. OrthoAccel was founded in 2007 to commercialize research conducted by Dr. Jeremy Mao, DDS, PhD and Professor, Columbia University College of Dental Medicine.
Source: OrthoAccel Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.